Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encer for Cancer Treatment-Related Fatigue
NCT07707648Phase 1Completed
- Sponsor
- Beaura
- Start
- Oct 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in fatigue (2 arms), sponsored by Beaura. Primary endpoint: Adverse Events or Serious Adverse Events at 12 weeks. Started Oct 2025; status: completed.
02
Conditions
fatigue
Beyond the preview
Go deeper on NCT07707648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707648.